Ce site utilise des cookies dans le but de vous fournir un service plus réactif et personnalisé. Merci de bien vouloir lire la notice d'information sur les cookies et comment les effacer et les bloquer.

Enregistrer dans les favoris E-mail Imprimer cette page

Winning in Life Sciences

Navigating a complex industry

Winning in Life Sciences

In this post-recession era, many global health systems will be impacted by a series of austerity measures. Pricing and re-imbursement pressures, high hurdles for innovation, and the need to demonstrate economic value can only get more severe. Patent expiry, and the lack of new products coming to market, means that life sciences companies will struggle to deliver top-line growth. Companies have re-structured their commercial models to meet the demands of the mature health markets and to focus on value and market access.

Restez connectés
Nous contacter